tiprankstipranks
Trending News
More News >
Upstream Bio, Inc. (UPB)
NASDAQ:UPB
US Market

Compare Upstream Bio, Inc. (UPB) vs. Competitors

Compare
165 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Upstream Bio, Inc.
$26.97
$1.68B
-13.57
184.93%
8 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$20.01
$1.01B
35.57
137.09%
4 Buy
1 Hold
0 Sell
Strong Buy
Bicycle Therapeutics
$6.51
$451.19M
-52.10%
6 Buy
3 Hold
0 Sell
Moderate Buy
Prime Medicine, Inc.
$3.98
$718.43M
-2.70
38.68%
4 Buy
3 Hold
0 Sell
Moderate Buy
Bicara Therapeutics Inc.
$16.75
$917.60M
-7.51
40.99%
8 Buy
2 Hold
0 Sell
Strong Buy
Zenas BioPharma, Inc.
$20.16
$1.08B
-4.45
159.13%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
UPB
Upstream Bio, Inc.
31.00
20.19
186.77%
TBPH
Theravance Biopharma
20.01
10.86
118.69%
BCYC
Bicycle Therapeutics
6.51
-7.05
-51.99%
PRME
Prime Medicine, Inc.
3.98
1.07
36.77%
BCAX
Bicara Therapeutics Inc.
16.75
4.67
38.66%
ZBIO
Zenas BioPharma, Inc.
20.16
11.76
140.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts